Perfluorochemicals and endometriosis: the ENDO study
Germaine M Buck Louis, Zhian Chen, Linda C Giudice, Kurunthachalam Kannan, Anne Kennedy, C Matthew Peterson, Joseph B Stanford, Lei Sun, Rajeshwari Sundaram, Michael W Varner, Qing Wu, Mary S Croughan, Victor Y Fujimoto, Mary L Hediger
Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentROR
Environmental chemicals may be associated with endometriosis. No published research has focused on the possible role of perfluorochemicals (PFCs) despite their widespread presence in human tissues.
Methods
We formulated two samples. The first was an operative sample comprising 495 women aged 18-44 years scheduled for laparoscopy/laparotomy at one of 14 participating clinical sites in the Salt Lake City or San Francisco area, 2007-2009. The second was a population-based sample comprising 131 women matched to the operative sample on age and residence within a 50-mile radius of participating clinics. Interviews and anthropometric assessments were conducted at enrollment, along with blood collection for the analysis of nine PFCs, which were quantified using liquid chromatography-tandem mass spectrometry. Endometriosis was defined based on surgical visualization (in the operative sample) or magnetic resonance imaging (in the population sample). Using logistic regression, we estimated odds ratios (ORs) and 95% confidence intervals (CIs) for each PFC (log-transformed), adjusting for age and body mass index, and then parity.
Results
Serum perfluorooctanoic acid (PFOA; OR = 1.89 [95% CI = 1.17-3.06]) and perfluorononanoic acid (2.20 [1.02-4.75]) were associated with endometriosis in the operative sample; findings were moderately attenuated with parity adjustment (1.62 [0.99-2.66] and 1.99 [0.91-4.33], respectively). Perfluorooctane sulfonic acid (1.86 [1.05-3.30]) and PFOA (2.58 [1.18-5.64]) increased the odds for moderate/severe endometriosis, although the odds were similarly attenuated with parity adjustment (OR = 1.50 and 1.86, respectively).
Conclusions
Select PFCs were associated with an endometriosis diagnosis. These associations await corroboration.
PMID 22992575 22992575 DOI 10.1097/EDE.0b013e31826cc0cf 10.1097/EDE.0b013e31826cc0cf
Cite this article
Louis, G. M. B., Peterson, C. M., Chen, Z., Hediger, M. L., Croughan, M. S., Sundaram, R., Stanford, J. B., Fujimoto, V. Y., Varner, M. W., Giudice, L. C., Kennedy, A., Sun, L., Wu, Q., & Kannan, K. (2012). Perfluorochemicals and endometriosis: the ENDO study. *Epidemiology (Cambridge, Mass.)*, *23*(6), 799-805. https://doi.org/10.1097/EDE.0b013e31826cc0cf
Louis GMB, Peterson CM, Chen Z, Hediger ML, Croughan MS, Sundaram R, et al. Perfluorochemicals and endometriosis: the ENDO study. Epidemiology. 2012;23(6):799-805. doi:10.1097/EDE.0b013e31826cc0cf
Louis, G. M. B., et al. "Perfluorochemicals and endometriosis: the ENDO study." *Epidemiology (Cambridge, Mass.)*, vol. 23, no. 6, 2012, pp. 799-805.
Buck Louis GM et al., 2012
Open Access
Environmental Health Perspectives
BACKGROUND: An equivocal literature exists regarding the relation between persistent organochlorine pollutants (POPs) and endometriosis in women, with differences attributed to methodologies.
OBJECTI...
The development of highly potent gonadotropin-releasing hormone agonists (GnRHa) allowed for a significant addition to options for the medical management of symptomatic endometriosis. Pituitary GnRH r...
Arangia A et al., 2023
Open Access
International Journal of Molecular Sciences
A chronic, painful, and inflammatory condition known as endometriosis is defined by the extra-uterine development of endometrial tissue. The aim of this study was to evaluate the beneficial effects of...